{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T12:28:45Z","timestamp":1770812925576,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100019914","name":"Flatiron Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019914","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15548-8","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T04:24:24Z","timestamp":1768019064000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Real-world evidence from Germany: representativeness analysis and mortality endpoint validation in electronic health record-derived oncology cohorts"],"prefix":"10.1186","volume":"26","author":[{"given":"Blythe","family":"Adamson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sascha","family":"van Boemmel-Wegmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsie","family":"Horne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lana","family":"Kovacevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nada","family":"Boualam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Somavanshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Dorst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun","family":"Sujenthiran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Buhl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"key":"15548_CR1","unstructured":"Ronckers C, Spix C, Tr\u00fcbenbach C, Katalinic A, Christ M, Cicero A, et al. Krebs in Deutschland f\u00fcr 2019\/2020. 2023. https:\/\/edoc.rki.de\/handle\/176904\/11438."},{"key":"15548_CR2","doi-asserted-by":"publisher","DOI":"10.1200\/cci.23.00261","volume":"8","author":"CC Lerro","year":"2024","unstructured":"Lerro CC, Bradley MC, Forshee RA, Rivera DR. The bar is high: evaluating fit-for-use oncology real-world data for regulatory decision making. JCO Clin Cancer Inform. 2024;8:e2300261. https:\/\/doi.org\/10.1200\/cci.23.00261.","journal-title":"JCO Clin Cancer Inform"},{"key":"15548_CR3","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/cpt.3596","volume":"117","author":"P Arlett","year":"2025","unstructured":"Arlett P, Umuhire D, Verpillat P, Foggi P, Liminga UW, Sepodes B, et al. Clinical Evidence 2030. Clin Pharmacol Ther. 2025;117:884\u20136. https:\/\/doi.org\/10.1002\/cpt.3596.","journal-title":"Clin Pharmacol Ther"},{"key":"15548_CR4","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/cpt.3563","volume":"117","author":"RK Hernandez","year":"2025","unstructured":"Hernandez RK, Critchlow CW, Dreyer N, Lash TL, Reynolds RF, S\u00f8rensen HT, et al. Advancing principled pharmacoepidemiologic research to support regulatory and healthcare decision making: the era of real-world evidence. Clin Pharmacol Ther. 2025;117:927\u201337. https:\/\/doi.org\/10.1002\/cpt.3563.","journal-title":"Clin Pharmacol Ther"},{"key":"15548_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-074566","volume":"14","author":"K Moser","year":"2024","unstructured":"Moser K, Massag J, Frese T, Mikolajczyk R, Christoph J, Pushpa J, et al. German primary care data collection projects: a scoping review. BMJ Open. 2024;14:e074566. https:\/\/doi.org\/10.1136\/bmjopen-2023-074566.","journal-title":"BMJ Open"},{"key":"15548_CR6","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s00439-018-1912-1","volume":"137","author":"F Moln\u00e1r-G\u00e1bor","year":"2018","unstructured":"Moln\u00e1r-G\u00e1bor F. Germany: a fair balance between scientific freedom and data subjects\u2019 rights? Hum Genet. 2018;137:619\u201326. https:\/\/doi.org\/10.1007\/s00439-018-1912-1.","journal-title":"Hum Genet"},{"key":"15548_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15153934","volume":"15","author":"A Katalinic","year":"2023","unstructured":"Katalinic A, Halber M, Meyer M, Pfl\u00fcger M, Eberle A, Nennecke A, et al. Population-based clinical cancer registration in Germany. Cancers. 2023;15:3934. https:\/\/doi.org\/10.3390\/cancers15153934.","journal-title":"Cancers"},{"key":"15548_CR8","doi-asserted-by":"publisher","DOI":"10.2196\/15102","volume":"22","author":"S Pohlmann","year":"2020","unstructured":"Pohlmann S, Kunz A, Ose D, Winkler EC, Brandner A, Poss-Doering R, et al. Digitalizing health services by implementing a personal electronic health record in Germany: qualitative analysis of fundamental prerequisites from the perspective of selected experts. J Med Internet Res. 2020;22:e15102. https:\/\/doi.org\/10.2196\/15102.","journal-title":"J Med Internet Res"},{"key":"15548_CR9","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jval.2024.01.019","volume":"27","author":"RL Fleurence","year":"2024","unstructured":"Fleurence RL, Kent S, Adamson B, Tcheng J, Balicer R, Ross JS, et al. Assessing real-world data from electronic health records for health technology assessment: the SUITABILITY checklist: a good practices report of an ISPOR task force. Value Health. 2024;27:692\u2013701. https:\/\/doi.org\/10.1016\/j.jval.2024.01.019.","journal-title":"Value Health"},{"issue":"11_Supplement","key":"15548_CR10","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.7326\/m19-0873","volume":"172","author":"A Callahan","year":"2020","unstructured":"Callahan A, Shah NH, Chen JH. Research and reporting considerations for observational studies using electronic health record data. Ann Intern Med. 2020;172(11_Supplement):S79-84. https:\/\/doi.org\/10.7326\/m19-0873.","journal-title":"Ann Intern Med"},{"key":"15548_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1109978","volume":"13","author":"F Giusti","year":"2023","unstructured":"Giusti F, Martos C, Trama A, Bettio M, Sanvisens A, Audisio R, et al. Cancer treatment data available in European cancer registries: where are we and where are we going? Front Oncol. 2023;13:1109978. https:\/\/doi.org\/10.3389\/fonc.2023.1109978.","journal-title":"Front Oncol"},{"key":"15548_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmorw.2025.100113","volume":"7","author":"B Adamson","year":"2025","unstructured":"Adamson B, Horne E, Xu C, Samani A, Buhl C, Mpofu P, et al. Characterisation of oncology EHR-derived real-world data in the UK, Germany, and Japan. ESMO Real World Data and Digital Oncology. 2025;7:100113. https:\/\/doi.org\/10.1016\/j.esmorw.2025.100113.","journal-title":"ESMO Real World Data and Digital Oncology"},{"key":"15548_CR13","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.4727892","author":"T Gerke","year":"2024","unstructured":"Gerke T, Ackerman B, Long L, Baxi S, Miksad R, Adamson B, et al. Representativeness of real world data: A framework for assessing oncology EHR-derived data. SSRN Electron J. 2024. https:\/\/doi.org\/10.2139\/ssrn.4727892.","journal-title":"SSRN Electron J"},{"key":"15548_CR14","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1111\/1475-6773.13669","volume":"56","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Gossai A, Monroe S, Nussbaum NC, Parrinello CM. Validation analysis of a composite real-world mortality endpoint for patients with cancer in the united States. Health Serv Res. 2021;56:1281\u20137. https:\/\/doi.org\/10.1111\/1475-6773.13669.","journal-title":"Health Serv Res"},{"key":"15548_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10549-023-07048-1","volume":"202","author":"N Gremke","year":"2023","unstructured":"Gremke N, Wagner U, Kalder M, Kostev K. Changes in the incidence of early-onset breast cancer in Germany between 2010 and 2022. Breast Cancer Res Treat. 2023;202:167\u201372. https:\/\/doi.org\/10.1007\/s10549-023-07048-1.","journal-title":"Breast Cancer Res Treat"},{"key":"15548_CR16","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1055\/a-1160-5569","volume":"80","author":"J H\u00fcbner","year":"2020","unstructured":"H\u00fcbner J, Katalinic A, Waldmann A, Kraywinkel K. Long-term incidence and mortality trends for breast cancer in Germany. Geburtshilfe Frauenheilkd. 2020;80:611\u20138. https:\/\/doi.org\/10.1055\/a-1160-5569.","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"15548_CR17","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/modpathol.2016.164","volume":"30","author":"J R\u00fcschoff","year":"2017","unstructured":"R\u00fcschoff J, Lebeau A, Kreipe H, Sinn P, Gerharz CD, Koch W, et al. Assessing HER2 testing quality in breast cancer: variables that influence HER2 positivity rate from a large, multicenter, observational study in Germany. Mod Pathol. 2017;30:217\u201326. https:\/\/doi.org\/10.1038\/modpathol.2016.164.","journal-title":"Mod Pathol"},{"key":"15548_CR18","doi-asserted-by":"publisher","unstructured":"Dannehl D, von Au A, Engler T, Volmer LL, Gutsfeld R, Englisch JF, et al. Cancers. 2024;16:1490. Implementation and Evaluation of a Breast Cancer Disease Model Using Real-World Claims Data in Germany from 2010 to 2020.\u00a0https:\/\/doi.org\/10.3390\/cancers16081490.\u00a0","DOI":"10.3390\/cancers16081490"},{"key":"15548_CR19","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.breast.2019.12.005","volume":"49","author":"J R\u00fcschoff","year":"2020","unstructured":"R\u00fcschoff J, Lebeau A, Sinn P, Schildhaus H-U, Decker T, Ammann J, et al. Statistical modelling of HER2-positivity in breast cancer: final analyses from two large, multicentre, non-interventional studies in Germany. Breast. 2020;49:246\u201353. https:\/\/doi.org\/10.1016\/j.breast.2019.12.005.","journal-title":"Breast"},{"key":"15548_CR20","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/ijc.32767","volume":"147","author":"A Katalinic","year":"2020","unstructured":"Katalinic A, Eisemann N, Kraywinkel K, Noftz MR, H\u00fcbner J. Breast cancer incidence and mortality before and after implementation of the German mammography screening program. Int J Cancer. 2020;147:709\u201318. https:\/\/doi.org\/10.1002\/ijc.32767.","journal-title":"Int J Cancer"},{"key":"15548_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12092419","volume":"12","author":"L Jansen","year":"2020","unstructured":"Jansen L, Holleczek B, Kraywinkel K, Weberpals J, Schr\u00f6der CC, Eberle A, et al. Divergent patterns and trends in breast cancer incidence, mortality and survival among older women in Germany and the united States. Cancers. 2020;12:2419. https:\/\/doi.org\/10.3390\/cancers12092419.","journal-title":"Cancers"},{"key":"15548_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2022.07.477","volume":"17","author":"M Stuschke","year":"2022","unstructured":"Stuschke M, Eberhardt W, Passlick B, Groeschel A, Christopoulos P, Reck M, et al. EP05.01-030 crisp: first real-world evidence of NSCLC stage I, II and III in Germany - AIO-TRK-0315. J Thorac Oncol. 2022;17:S280. https:\/\/doi.org\/10.1016\/j.jtho.2022.07.477.","journal-title":"J Thorac Oncol"},{"key":"15548_CR23","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.lungcan.2020.10.012","volume":"152","author":"F Griesinger","year":"2021","unstructured":"Griesinger F, Eberhardt W, Nusch A, Reiser M, Zahn M-O, Maintz C, et al. Biomarker testing in non-small cell lung cancer in routine care: analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315). Lung Cancer. 2021;152:174\u201384. https:\/\/doi.org\/10.1016\/j.lungcan.2020.10.012.","journal-title":"Lung Cancer"},{"key":"15548_CR24","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1186\/s12885-023-11660-1","volume":"23","author":"A Waldmann","year":"2023","unstructured":"Waldmann A, Borchers P, Katalinic A. Temporal trends in age- and stage-specific incidence of colorectal adenocarcinomas in Germany. BMC Cancer. 2023;23:1180. https:\/\/doi.org\/10.1186\/s12885-023-11660-1.","journal-title":"BMC Cancer"},{"key":"15548_CR25","unstructured":"der WMF eVA, DK eV, Krebshilfe D. Kolorektales Karzinom. Leitlinieprogramm onkologie. 2019. https:\/\/www.leitlinienprogramm-onkologie.de\/leitlinien\/kolorektales-karzinom\/. Accessed 22 June 2025."},{"key":"15548_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15184474","volume":"15","author":"C Rudolph","year":"2023","unstructured":"Rudolph C, Engholm G, Pritzkuleit R, Storm HH, Katalinic A. Colorectal cancer survival in German\u2013Danish border regions\u2014a registry-based cohort study. Cancers. 2023;15:4474. https:\/\/doi.org\/10.3390\/cancers15184474.","journal-title":"Cancers"},{"key":"15548_CR27","unstructured":"Hofheinz RD, Arnold D, Borner M, Eisterer W, Faber G, Folprecht G, et al. Kolonkarzinom. Onkopedia. https:\/\/www.onkopedia.com\/de\/onkopedia\/guidelines\/kolonkarzinom\/@@guideline\/html\/index.html. Accessed 22 June 2025."},{"key":"15548_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15041022","volume":"15","author":"N Mulet-Margalef","year":"2023","unstructured":"Mulet-Margalef N, Linares J, Badia-Ramentol J, Jimeno M, Monte CS, Mozo JLM, et al. Challenges and therapeutic opportunities in the dMMR\/MSI-H colorectal cancer landscape. Cancers. 2023;15:1022. https:\/\/doi.org\/10.3390\/cancers15041022.","journal-title":"Cancers"},{"key":"15548_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1019582","volume":"13","author":"W-J Mei","year":"2022","unstructured":"Mei W-J, Mi M, Qian J, Xiao N, Yuan Y, Ding P-R. Clinicopathological characteristics of high microsatellite instability\/mismatch repair-deficient colorectal cancer: a narrative review. Front Immunol. 2022;13:1019582. https:\/\/doi.org\/10.3389\/fimmu.2022.1019582.","journal-title":"Front Immunol"},{"key":"15548_CR30","doi-asserted-by":"publisher","first-page":"100040","DOI":"10.1016\/j.esmorw.2024.100040","volume":"4","author":"N Marschner","year":"2024","unstructured":"Marschner N, Seufferlein T, Potthoff K, Zahn M-O, Uhlig J, D\u00f6rfel S, et al. Changes in survival of > 3800 patients with metastatic colorectal cancer in germany: results from a 16-year prospective longitudinal real-world data analysis. ESMO Real World Data Digit Oncol. 2024;4:100040. https:\/\/doi.org\/10.1016\/j.esmorw.2024.100040.","journal-title":"ESMO Real World Data Digit Oncol"},{"key":"15548_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16061219","volume":"16","author":"K Kostev","year":"2024","unstructured":"Kostev K, Krieg S, Krieg A, Luedde T, Loosen SH, Roderburg C. In-hospital mortality and associated factors among colorectal cancer patients in Germany. Cancers. 2024;16:1219. https:\/\/doi.org\/10.3390\/cancers16061219.","journal-title":"Cancers"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15548-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15548-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15548-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T13:50:42Z","timestamp":1770645042000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15548-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,10]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15548"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15548-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,10]]},"assertion":[{"value":"10 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The (non-interventional) study was conducted using anonymized data only. The researchers working on the analysis do not have access to any identifiable data. The datasets were assembled and anonymized on the basis of patient consent and in line with relevant exceptions under applicable national and European regulations (Art. 9 para. 2 (j) GDPR, Art. 27 German Federal Data Protection Act and Art. 6 German Health Data Use Act).Therefore no ethics approval is required according to Art. 15 of the German Professional Code for Physicians and Article 23 of the Declaration of Helsinki. Consent and ethics approval requirement under clinical trial regulation in conjunction with Art. 40, 41 German Medicines Act (Arzneimittelgesetz), Art. 62 Medical Device Regulation in conjunction with Art. 31, 31a Medical-Devices Implementation Act (Medizinprodukterecht- Durchf\u00fchrungsgesetz) and Art. 34 para. 2 No. 2 Radiation Protection Act (Strahlenschutz- Gesetz) are also not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors report current employment with Flatiron Health, Inc., Flatiron Health UK, or Flatiron Health Germany\u2014independent members of the Roche group. BA, SBW, EH, SS, QZ, LK, RS, AS, and CB report stock ownership in Roche.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"202"}}